Compile Data Set for Download or QSAR
Report error Found 14 Enz. Inhib. hit(s) with all data for entry = 50020880
TargetNuclear factor erythroid 2-related factor 2(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50504654(CHEBI:76004 | AZL 0 211089 | AZL O 211089 | AZL-02...)
Affinity DataEC50:  7.93E+3nMAssay Description:Activation of Nrf2 in human PathHunter U2OS Keap1-Nrf2 cells assessed as Nrf2 nuclear translocation by chemiluminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetNuclear factor erythroid 2-related factor 2(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50342426(4-methoxy-4-oxobut-2-enoic acid | methyl fumarate ...)
Affinity DataEC50:  1.27E+5nMAssay Description:Activation of Nrf2 in human PathHunter U2OS Keap1-Nrf2 cells assessed as Nrf2 nuclear translocation by chemiluminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetNuclear factor erythroid 2-related factor 2(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50634408(CHEMBL5415198)
Affinity DataEC50:  6.09E+4nMAssay Description:Activation of Nrf2 in human PathHunter U2OS Keap1-Nrf2 cells assessed as Nrf2 nuclear translocation by chemiluminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetNuclear factor erythroid 2-related factor 2(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50634409(CHEMBL5393772)
Affinity DataEC50:  8.72E+3nMAssay Description:Activation of Nrf2 in human PathHunter U2OS Keap1-Nrf2 cells assessed as Nrf2 nuclear translocation by chemiluminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetNuclear factor erythroid 2-related factor 2(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50634410(CHEMBL5433953)
Affinity DataEC50:  900nMAssay Description:Activation of Nrf2 in human PathHunter U2OS Keap1-Nrf2 cells assessed as Nrf2 nuclear translocation by chemiluminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetNuclear factor erythroid 2-related factor 2(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50634411(CHEMBL5393827)
Affinity DataEC50:  9.52E+4nMAssay Description:Activation of Nrf2 in human PathHunter U2OS Keap1-Nrf2 cells assessed as Nrf2 nuclear translocation by chemiluminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetNuclear factor erythroid 2-related factor 2(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50634412(CHEMBL5404675)
Affinity DataEC50: >1.00E+5nMAssay Description:Activation of Nrf2 in human PathHunter U2OS Keap1-Nrf2 cells assessed as Nrf2 nuclear translocation by chemiluminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetNuclear factor erythroid 2-related factor 2(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50634413(CHEMBL5440555)
Affinity DataEC50:  360nMAssay Description:Activation of Nrf2 in human PathHunter U2OS Keap1-Nrf2 cells assessed as Nrf2 nuclear translocation by chemiluminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetNuclear factor erythroid 2-related factor 2(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50634414(CHEMBL5408914)
Affinity DataEC50:  300nMAssay Description:Activation of Nrf2 in human PathHunter U2OS Keap1-Nrf2 cells assessed as Nrf2 nuclear translocation by chemiluminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetNuclear factor erythroid 2-related factor 2(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50634415(CHEMBL5437928)
Affinity DataEC50:  20nMAssay Description:Activation of Nrf2 in human PathHunter U2OS Keap1-Nrf2 cells assessed as Nrf2 nuclear translocation by chemiluminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetNuclear factor erythroid 2-related factor 2(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50634416(CHEMBL5425309)
Affinity DataEC50:  4.42E+3nMAssay Description:Activation of Nrf2 in human PathHunter U2OS Keap1-Nrf2 cells assessed as Nrf2 nuclear translocation by chemiluminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetNuclear factor erythroid 2-related factor 2(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50634417(CHEMBL5413156)
Affinity DataEC50:  1.05E+4nMAssay Description:Activation of Nrf2 in human PathHunter U2OS Keap1-Nrf2 cells assessed as Nrf2 nuclear translocation by chemiluminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetNuclear factor erythroid 2-related factor 2(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50634418(CHEMBL5430762)
Affinity DataEC50:  3.24E+4nMAssay Description:Activation of Nrf2 in human PathHunter U2OS Keap1-Nrf2 cells assessed as Nrf2 nuclear translocation by chemiluminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetNuclear factor erythroid 2-related factor 2(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50634419(CHEMBL5422691)
Affinity DataEC50:  5.00E+4nMAssay Description:Activation of Nrf2 in human PathHunter U2OS Keap1-Nrf2 cells assessed as Nrf2 nuclear translocation by chemiluminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed